Business
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough - CNBC
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
By: CNBC
- Sep 17 2024
- 0
- 0 Views
Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough.Â
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other pharmaceutical companies hav… [+8977 chars]